Follow-The-Filings

Security

Contineum Therapeutics Inc. · CL A

Equity holders as of 2026 Q1 (each manager’s latest book)

8 owners 1 new 1 exit max 0.0% (Dmitry Balyasny - Balyasn...)

owners 8
max % 0.0%
tracked value $67M
qoq N 1 A 4 R 2 E 1

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% Reduce 0.00 pp 1,685,635 $22M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add 0.00 pp 1,535,449 $20M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 1,270,858 $15M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% New 0.0% 350,200 $5M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Add 0.00 pp 226,302 $3M hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Reduce -0.01 pp 84,891 $1M hist
Renaissance Technologies LLC 2026 Q1 0.0% Add 0.00 pp 69,400 $906 hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 37,916 $433 hist
Norges Bank exited 2025 Q4 last 2025 Q2 0.0% Exit 0.00 pp 169,729 $674 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2024 FY2025
Revenue $0.00
Gross profit
Gross margin
Net income -$42.26M -$59.98M
Net margin

Balance sheet

Metric FY2024 FY2025
Total current assets $206.39M $267.92M
Total non-current assets * $6.46M $8.72M
Total assets $212.85M $276.64M
Total current liabilities $9.97M $9.74M
Total non-current liabilities * $4.81M $5.91M
Total equity $198.07M $260.99M

Cash flow

Metric FY2024 FY2025
Cash from operations -$32.84M -$55.31M
Cash from investing -$69.74M -$3.71M
Cash from financing $109M $112.68M
Net change in cash $6.42M $53.66M

ownership over time

filing count by report period · click a bar for that quarter’s holders